Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Surgery
Share your love
What’s in Store for ESCRS 2024? Workshops, Labs, and More
The European Society of Cataract and Refractive Surgeons (ESCRS) is gearing up for its 42nd Annual Congress with a rich lineup of initiatives designed to enhance learning, foster collaboration, and celebrate advancements in ophthalmology. This year’s event will feature a…
Exclusive: Key Events at ESCRS 2024
The 42nd of the European Society of Cataract and Refractive Surgeons (ESCRS) is poised to offer a dynamic array of events and initiatives in 2024, featuring a mix of educational programs, commemorative milestones, and new insights into key areas of…
Bausch + Lomb’s TENEO Laser Achieves Strong LASIK Outcomes
Bausch + Lomb recently published the results of a pivotal clinical trial for its TENEO™ Excimer Laser in the Journal of Refractive Surgery. This study, which played a crucial role in securing U.S. FDA approval for the device in January…
Link Between Proteins in Tears and Pain After Eye Surgery
In a study published in the Journal of Proteome Research, researchers from Oregon Health & Science University (OHSU) have identified a connection between specific proteins found in patients’ tears and persistent pain experienced months after eye surgery. This discovery could…
New Insights on Retinoblastoma Treatment
Recent research presented at the Society of NeuroInterventional Surgery’s (SNIS) 21st Annual Meeting underscores significant improvements in treating retinoblastoma, a rare eye cancer affecting young children. The study reveals that advancements in treatment over the past 15 years have notably…
Bausch + Lomb Acquires Trukera Medical
Bausch + Lomb has completed the acquisition of Trukera Medical, a US-based ophthalmic medical diagnostic company. The financial details of the acquisition were not disclosed. Trukera Medical’s Innovative ScoutPro Device Trukera Medical, previously owned by private equity firm AccelMed Partners…
Oertli Receives FDA Clearance for Faros Anterior System
Oertli Instrumente AG announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its globally established Faros anterior cataract surgery system. This milestone underscores Oertli’s expansive global presence and unwavering commitment to delivering advanced and reliable…
Osheru Receives Funding for Ziplyft Device for Blepharoplasty
Osheru announced the successful completion of a $4.7 million funding round aimed at accelerating the development and commercialization of its Ziplyft device for blepharoplasty surgery. The funding round was oversubscribed and led by a consortium of investors including individuals, family…
Samsara Vision Launches SING IMT in China
Samsara Vision announced the successful completion of the first SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope) procedure in China. This milestone was achieved at the First Affiliated Hospital of Hainan Medical University Lecheng Hospital, where Professor Li Xiaorong, MD, PhD,…
Okyo Pharma’s Phase 2 Trial for Neuropathic Corneal Pain
Okyo Pharma announced its plan to initiate a phase 2 clinical trial for OK-101 in the treatment of neuropathic corneal pain (NCP), scheduled to begin in the third quarter of 2024. This one-year study follows promising results from preclinical animal…